NCT03381638 is a clinical trial of Blink Reflexometer in Traumatic Brain Injury, sponsored by Blinktbi, Inc..

Who is sponsoring NCT03381638?

NCT03381638 is sponsored by Blinktbi, Inc..

What drugs are being tested in NCT03381638?

Interventions in NCT03381638: Blink Reflexometer.

What condition does NCT03381638 study?

NCT03381638 studies Traumatic Brain Injury, Concussion, Brain.

Is NCT03381638 still recruiting?

NCT03381638 is currently completed. Last updated 19 April 2018.

Last reviewed 2018-04-19 · How we verify

NCT03381638

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Understanding Concussion/Mild Traumatic Brain Injury

Completed Last updated 19 April 2018

What this trial tests

trial testing Blink Reflexometer in Traumatic Brain Injury in 477 participants. Completed in 17 April 2018.

Timeline

1 January 2016

Primary endpoint
17 April 2018

17 April 2018

Quick facts

Lead sponsor	Blinktbi, Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	477
Start date	1 January 2016
Primary completion	17 April 2018
Estimated completion	17 April 2018
Sites	5 locations across United States

Drugs / interventions tested

Blink Reflexometer

Conditions studied

Traumatic Brain Injury — all drugs for Traumatic Brain Injury →
Concussion, Brain — all drugs for Concussion, Brain →

Sponsor

Blinktbi, Inc.

Who can join

14 and older, any sex, with Traumatic Brain Injury or Concussion, Brain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Using the Blink Reflexometer, athletes are scanned if they are potentially thought to have a concussion during a game or practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Traumatic Brain Injury

Currently open trials in the same condition.

NCT07176936 — Improving Speech in Noise Using Noninvasive Stimulation · NA · recruiting
NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
NCT07455136 — A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Mon · recruiting
NCT07404761 — Safety and Effectiveness of Spatial StimelMD (SSMD) in Subjects With Upper Limb Neuromotor Impairments · NA · recruiting
NCT07230002 — Effects of Moderate/Severe Traumatic Brain Injury in the Subacute or Chronic Phase on Locomotor Strategies Involved in N · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03381638 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Blinktbi, Inc.
Last refreshed: 19 April 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03381638.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing